SIGAR's latest quarterly report to the U.S. Congress highlights challenges in counternarcotics efforts and examines how a lack of transparency in funding is contributing to record-high opium production.
Sign in or join Devex to read the rest
Not only will you get to finish this article, you will also unlock access to community content from our global team of journalists covering the latest global health, humanitarian aid and international development news. And it's totally free.
